Cell Therapeutics CEO James Bianco: An Interview With “The Pink Sheet” DAILY
Seattle biotech is looking to “build a more integrated portfolio” with offer to purchase Miami-based DOR BioPharma, Bianco says.
Seattle biotech is looking to “build a more integrated portfolio” with offer to purchase Miami-based DOR BioPharma, Bianco says.